Lv1
90 积分 2023-08-11 加入
Adjuvant transarterial chemoembolization for hepatocellular carcinoma following curative resection: A randomized, open-label, phase 3 trial
2天前
已完结
Adjuvant transarterial chemoembolization for intermediate-stage hepatocellular carcinoma with microvascular invasion
14天前
已完结
Multicenter, retrospective GUIDANCE001 study comparing transarterial chemoembolization with or without tyrosine kinase and immune checkpoint inhibitors as conversion therapy to treat unresectable hepatocellular carcinoma: Survival benefit in intermediate or advanced, but not early, stages
1个月前
已完结
Adjuvant transarterial chemoembolization for intermediate-stage hepatocellular carcinoma with microvascular invasion
1个月前
已完结
Prognostic significance of nodular number in patients undergoing hepatectomy of intermediate-stage hepatocellular carcinoma
2个月前
已完结
Adjuvant and neoadjuvant immunotherapies in hepatocellular carcinoma
2个月前
已完结
Immune checkpoint inhibitors in hepatocellular carcinoma: emerging challenges in clinical practice
2个月前
已完结
Chromatin remodelling drives immune cell–fibroblast communication in heart failure
3个月前
已完结
Comparison of prognostic impact of atezolizumab plus bevacizumab versus lenvatinib in patients with intermediate-stage hepatocellular carcinoma
4个月前
已完结
Survival in Patients With Recurrent Intermediate-Stage Hepatocellular Carcinoma: Sorafenib Plus TACE vs TACE Alone Randomized Clinical Trial
4个月前
已完结
皖公网安备34019202002308
